Niranjan Sardesai

Company: Geneos Therapeutics

Job title: Co-Founder, President & Chief Executive Officer

Seminars:

GT-EPIC™ Platform Based Personalized Cancer Vaccines to Treat Patients with Advanced Hepatocellular Carcinoma in Combination with PD1 Checkpoint Immunotherapy 3:00 pm

Sharing clinical data highlighting objective responses evaluated via RECIST 1.1 Understanding what can biomarkers inform us for predicting cancer vaccine driven clinical and immunological responses in checkpoint combinationsRead more

day: Day One